Literature DB >> 23456161

Bilateral bisphosphonate-related osteonecrosis of the jaw with left chronic infection in an 82-year-old woman.

Laure Gallay1, Anne-Gaëlle Bodard, Christian Chidiac, Tristan Ferry.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23456161      PMCID: PMC3618777          DOI: 10.1136/bcr-2013-008558

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


× No keyword cloud information.
  3 in total

1.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.

Authors: 
Journal:  J Oral Maxillofac Surg       Date:  2007-03       Impact factor: 1.895

2.  Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces.

Authors:  Nimesh H Naik; Thomas A Russo
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

3.  Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals.

Authors:  Christos Magopoulos; Georgios Karakinaris; Zisis Telioudis; Konstantinos Vahtsevanos; Ioannis Dimitrakopoulos; Konstantinos Antoniadis; Sideris Delaroudis
Journal:  Am J Otolaryngol       Date:  2007 May-Jun       Impact factor: 1.808

  3 in total
  3 in total

Review 1.  Actinomycosis: etiology, clinical features, diagnosis, treatment, and management.

Authors:  Florent Valour; Agathe Sénéchal; Céline Dupieux; Judith Karsenty; Sébastien Lustig; Pierre Breton; Arnaud Gleizal; Loïc Boussel; Frédéric Laurent; Evelyne Braun; Christian Chidiac; Florence Ader; Tristan Ferry
Journal:  Infect Drug Resist       Date:  2014-07-05       Impact factor: 4.003

Review 2.  Microbiological and Clinical Aspects of Cervicofacial Actinomyces Infections: An Overview.

Authors:  Márió Gajdács; Edit Urbán; Gabriella Terhes
Journal:  Dent J (Basel)       Date:  2019-09-01

3.  Comments on " Cutaneous Abscess as a Complication of Bisphosphonate-Related Osteonecrosis of the Jaw " by Yang et al.

Authors:  Atousa Hakamifard
Journal:  Ann Dermatol       Date:  2019-07-01       Impact factor: 1.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.